Browsing by Author "Graupera, Isabel"

Sort by: Order: Results:

  • High frequency of acute decompensation and cancer in patients with compensated cirrhosis due to nonalcoholic fatty liver disease: A retrospective cohort study
    Bassegoda, Octavi; Rivera-Esteban, Jesús; Serra, Isabel; Morillas, Rosa M.; Broquetas, Teresa; Vergara, Mercè; Rodriguez, Adrià; Aracil, Carles; Virolés, Silvia; Carrión Rodríguez, José Antonio; Pardo, Alberto; Rodríguez-Tajes, Sergio; Serra Burriel, Miquel; Pericàs, Juan; Augustin, Salvador; Ginès, Pere; Graupera, Isabel (Wiley, 2022)
    The natural history of compensated cirrhosis due to nonalcoholic fatty liver disease (NAFLD) has not been completely characterized. The aim of the present study was to assess the incidence and risk factors of acute ...
  • High prevalence of liver fibrosis among european adults with unknown liver disease: a population-based study
    Caballería, Llorenç; Pera, Guillem; Arteaga, Ingrid; Rodríguez, Lluís; Alumà, Alba; Morillas, Rosa M.ª; Ossa, Napoleón de la; Díaz, Alba; Expósito, Carmen; Miranda, Dolores; Sánchez, Carmen; Prats, Rosa M.ª; Urquizu, Marta; Salgado, Àngels; Alemany, Magda; Martínez, Alba; Majeed, Irfan; Fabrellas, Núria; Graupera, Isabel; Planas, Ramón; Ojanguren, Isabel; Serra Burriel, Miquel; Torán, Pere; Caballería, Juan; Ginès, Pere (Elsevier, 2018)
  • Impact of the COVID-19 pandemic on the care and outcomes of people with NAFLD-related cirrhosis
    Rivera-Esteban, Jesús; Manzano-Nuñez, Ramiro; Broquetas, Teresa; Serra-Matamala, Isabel; Bassegoda, Octavi; Soriano-Varela, Agnès; Espín, Gemma; Castillo, Joaquín; Bañares, Juan; Carrión Rodríguez, José Antonio; Ginès, Pere; Graupera, Isabel; Pericàs, Juan (Elsevier, 2022)
    Background & aims: The COVID-19 pandemic has had a major negative impact on health systems and many chronic diseases globally. We aimed to evaluate the impact of the first year of the pandemic on the outcomes of people ...
  • LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
    Graupera, Isabel; García-Retortillo, Montserrat; Ginès, Pere; LiverScreen Consortium Investigators (BioMed Central, 2022)
    Background: the development of liver cirrhosis is usually an asymptomatic process until late stages when complications occur. The potential reversibility of the disease is dependent on early diagnosis of liver fibrosis and ...
  • Recomendaciones para la detección, diagnóstico y seguimiento de los pacientes con enfermedad por hígado graso no alcohólico en atención primaria y hospitalaria
    Caballeria, Llorenc; Augustin, Salvador; Broquetas, Teresa; Morillas, Rosa M.; Vergara, Mercè; Virolés, Silvia; Hernández, Mª Rosario; Serra, Isabel; Goday Arno, Alberto; Vila, Lluis; Siso-Almirall, Antonio; Solans, Rosa; Fernández Real, Jose M.; Carrión Rodríguez, José Antonio; Graupera, Isabel; Ginès, Pere (Elsevier, 2019)
    La enfermedad por hígado graso no alcohólico (EHGNA) es una de las enfermedades hepáticas crónicas más frecuentes, con una prevalencia del 20-30% en la población general y del 60-80% en poblaciones de riesgo. En un porcentaje ...
  • Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia
    Serra Burriel, Miquel; Graupera, Isabel; Toran, Pere; Thiele, Maja; Roulot, Dominique; Wai-Sun Wong, Vincent; Neil Guha, Indra; Fabrellas, Núria; Arslanow, Anita; Expósito, Carmen; Hernández, Rosario; Lai-Hung Wong, Grace; Harman, David; Darwish Murad, Sarwa; Krag, Aleksander; Pera, Guillem; Angeli, Paolo; Galle, Peter; Aithal, Guruprasad; Caballeria, Llorenc; Castera, Laurent; Ginès, Pere; Lammert, Frank (Elsevier, 2019)
    Background & Aims Non-alcoholic fatty liver disease and alcohol-related liver disease pose an important challenge to current clinical healthcare pathways because of the large number of at-risk patients. Therefore, we aimed ...